Stay Strong 777
liked
$Immuneering (IMRX.US)$
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer
Immuneering (Nasdaq: IMRX) has received FDA Fast Track designation for IMM-1-104 as a first-line treatment for pancreatic ductal adenocarcinoma (PDAC).
This follows the February 2024 Fast...
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer
Immuneering (Nasdaq: IMRX) has received FDA Fast Track designation for IMM-1-104 as a first-line treatment for pancreatic ductal adenocarcinoma (PDAC).
This follows the February 2024 Fast...
1
Stay Strong 777
commented on and voted
Hi, mooers!
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Apple's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Apple and earn plenty of rewards! Don't miss the chance to win big>>
$Apple (AAPL.US)$ is releasing its Q3 FY2024 earnings on August 1 after the bell. Unlock insights with Apple Earnings Hub>>
For the details of i...
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Apple's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Apple and earn plenty of rewards! Don't miss the chance to win big>>
$Apple (AAPL.US)$ is releasing its Q3 FY2024 earnings on August 1 after the bell. Unlock insights with Apple Earnings Hub>>
For the details of i...
103
191
Stay Strong 777
liked
$Maxeon Solar Technologies (MAXN.US)$ Sometimes even day trading a longer timeframe can be very helpful to make trade decisions! Do me a favor and switch you chart to the 1 hour timeframe and look at the uptrend overall that this is on! and it’s following the 7MA beautifully! Just felt like sharing what helps me with deciding what to do especially after im already bought in! Enjoy
10
9
Stay Strong 777
liked and commented on
$JIADE (JDZG.US)$ This is a pump and dump stock as you can see that its been pumped up within two days by scammers from $4 to 12+. Scammers are recommending this stock now through investments group on Whats App or Telegram. Please use your common sense to trade this stock at your own risk here with your hard earned money. DONT ENTER OR EXIT NOW BEFORE ITS TOO LATE!
10
7
Stay Strong 777
commented on
$Annexon (ANNX.US)$ def under 5 at open
1
Stay Strong 777
liked
$Tharimmune (THAR.US)$
Tharimmune to Present at 2024 BIO International Convention
Tharimmune, a clinical-stage biotech firm specializing in inflammation and immunology therapies, will present at the 2024 BIO International Convention from June 3-6 in San Diego. The company will showcase its therapeutic candidates and hold one-on-one meetings with investors and industry leaders. The presentation is scheduled for June 3 at 1:45 p.m. PT in Company Presentation Theater 3. Interested parties can ar...
Tharimmune to Present at 2024 BIO International Convention
Tharimmune, a clinical-stage biotech firm specializing in inflammation and immunology therapies, will present at the 2024 BIO International Convention from June 3-6 in San Diego. The company will showcase its therapeutic candidates and hold one-on-one meetings with investors and industry leaders. The presentation is scheduled for June 3 at 1:45 p.m. PT in Company Presentation Theater 3. Interested parties can ar...
2
3
Stay Strong 777
liked
$Zapata Computing (ZPTA.US)$
RUN!![]()
NVDA ER
$NVIDIA(NVDA.US)$
IMPRESSIVE YoY increases!
Revenue $26.0 billion, an increase of 18% from Q4 and 262% year-over-year.
Data Center revenue also reached a record $22.6 billion, up 23% from Q4 and 427% year-over-year.
GAAP earnings per share were $5.98, up 21% from Q4 and 629% year-over-year
Non-GAAP earnings per share were $6.12, up 19% from Q4 and 461% year-over-year.
RUN!
NVDA ER
$NVIDIA(NVDA.US)$
IMPRESSIVE YoY increases!
Revenue $26.0 billion, an increase of 18% from Q4 and 262% year-over-year.
Data Center revenue also reached a record $22.6 billion, up 23% from Q4 and 427% year-over-year.
GAAP earnings per share were $5.98, up 21% from Q4 and 629% year-over-year
Non-GAAP earnings per share were $6.12, up 19% from Q4 and 461% year-over-year.
1
9
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)